0 items

in your cart

Prescription Drug Search

Strengths available for Capecitabine :

Capecitabine 150mg
Capecitabine 500mg

Search for a drug:


Browse Alphabetically:

A · B · C · D · E · F · G · H · I · J · K · L · M · N
O · P · Q · R · S · T · U · V · W · X · Y · Z · #

Information about ExpressMedsCanada.com

SSL Secured Website Certified Global Pharmacy Network Hacker Proof: Safe Shopping Experience 5th Anniversary 2002-2007

List of countries where we can ship Capecitabine:

  • Armenia
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Barbados
  • Belarus
  • Brazil
  • Cayman Islands
  • Chile
  • Colombia
  • Cuba
  • Cyprus
  • Czech Republic
  • Fiji
  • Guadeloupe
  • Hong Kong
  • Hungary
  • India
  • Jamaica
  • Latvia
  • Liechtenstein
  • Lithuania
  • Mauritius
  • Moldova, Republic of
  • Netherlands
  • Peru
  • Philippines
  • Portugal
  • Saudi Arabia
  • Spain
  • Switzerland
  • Taiwan
  • Tonga
  • Ukraine
  • United Kingdom, UK
  • United States, US
  • Uzbekistan
  • Vanuatu
  • Vietnam
View All Countries

Latest news releases on Capecitabine:

Combining Capecitabine and Temsirolimus Safe and Effective in Patients With Advanced Malignancies - Med India

Combining capecitabine and temsirolimus for treating advanced malignancies is effective and can safely be given to patients, according to a phase I study looking into whether the combination of the two agents is safe for patients. In addition ...

Phase I study of temsirolimus, capecitabine proves safe; positive survival trend seen - medicalxpress.com

A phase I clinical trial examining the safety of combining temsirolimus and capecitabine in advanced malignancies suggests the two agents can be given safely to patients. In addition, the Georgetown Lombardi Comprehensive Cancer Center ...

GI Cancers: Promising Data Across the Board - Medscape News

We have an interesting trial looking at the combination of capecitabine and an AKT inhibitor (perifosine) vs capecitabine alone. [4] Another randomized trial looked at the oral multikinase inhibitor regorafenib and its role in exactly the same position.

Genta Reports Results Of Tesetaxel Confirmatory Trial - RTT News

The company said that the 2nd-line study enrolled 53 patients who had progressed on at least one prior chemotherapy regimen that included a platinum compound (cisplatin, oxaliplatin, or carboplatin) and a fluoropyrimidine (5-fluorouracil, capecitabine ...

Undaunted by Wall Street “Penalty Box,” Keryx Focuses on Kidney Drug - Xconomy

In an earlier trial with 38 patients, the drug looked promising in combination with a Roche product called capecitabine (Xeloda): It extended median survival from seven to 17 months compared with capecitabine alone. But those results couldn’t ...

ASCO Preview: Eight Cancer Drugs to Watch at the Big Show - Xconomy

These women had previously gotten Herceptin, and were randomly assigned to get either T-DM1 or a combo of GlaxoSmithKline’s lapatinib (Tykerb) and capecitabine (Xeloda) chemotherapy. Partly because this drug is working against a high-profile ...

5 Biotech Stocks At Rock Bottom Price With Takeover Possibility - Seekingalpha.com

On April 2, 2012, Keryx announced that the Phase 3 "X-PECT" (Xeloda & Perifosine Evaluation in Colorectal cancer Treatment) clinical trial evaluating perifosine (KRX-0401) & capecitabine (Xeloda) in patients with refractory advanced colorectal cancer did ...

SCRI Investigators are Authors on 60 Abstracts to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting - StreetInsider.com

Johanna C. Bendell, M.D., SCRI Director, GI Cancer Research Program is the first author and presenter of one of the Best of ASCO abstracts: a phase III randomized double-blind placebo-controlled study of perifosine plus capecitabine (P-CAP) vs. placebo ...

Genta Announces Results of Tesetaxel Confirmatory Trial in Patients With Advanced Gastric Cancer - GlobeNewsWire (press release)

In this "all-oral" chemotherapy program, all patients receive capecitabine, and they are randomly assigned to receive tesetaxel or placebo. The primary endpoint of the TESEGAST trial is overall survival. "With this study, Genta has completed an ...

Customer Service
1-866-799-3435 - Use Discount Code 7500 | Contact Form
Copyright © 2012 ExpressMedsCanada.com All rights reserved. Disclaimer | Privacy Policy
Accepted Credit Cards and Payment: VISA, MASTERCARD and eCHECK